title: American Diabetes Association - 76th Scientific Sessions (June 10-14, 2016 - New Orleans, Louisiana, USA).
abstract: The 76th American Diabetes Association (ADA) Scientific Sessions took place in New Orleans, Louisiana, USA. The meeting brought together scientists and professionals from a wide range of disciplines in the field of diabetes and provided a platform for networking, allowing experts and researchers to share ideas and learn about the significant advances in diabetes research, treatment and care. Over the course of the 5 days, participants received exclusive access to more than 2,500 original research presentations.
authors.affiliation: Thomson Reuters, London, UK. sam.s.lam@thomsonreuters.com.
authors.forename: S
authors.initials: S
authors.lastname: Lam
mesh_terms: D001559:Benzhydryl Compounds / Q000627:therapeutic use; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D005960:Glucosides / Q000627:therapeutic use; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D010666:Phenylpropionates / Q000627:therapeutic use; D011758:Pyrroles / Q000627:therapeutic use
chemical_list: D001559:Benzhydryl Compounds; D005960:Glucosides; D007004:Hypoglycemic Agents; D010666:Phenylpropionates; D011758:Pyrroles; C529054:dapagliflozin; C000588741:saroglitazar; C570240:empagliflozin
keywords: Albiglutide; Dapagliflozin; Diabetes; Empagliflozin; Gla-300; MOD-6031; Saroglitazar; Sitagliptin; Vildagliptin; ZP-4982; ZP-5461